Partners Capital Investment Group’s Thermo Fisher Scientific TMO Stock Holding History

Partners Capital Investment Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,056	Closed	-$3.91M	–	171
2025 Q3	$3.91M	Hold	8,056	–	–	0.16%	76
2025 Q2	$3.27M	Sell	8,056 -10,697	-57%	-$4.47M	0.13%	81
2025 Q1	$9.33M	Buy	18,753 +8,774	+88%	+$4.75M	0.16%	74
2024 Q4	$5.19M	Sell	9,979 -9,398	-49%	-$5.17M	0.14%	61
2024 Q3	$12M	Sell	19,377 -1,111	-5%	-$658K	0.19%	59
2024 Q2	$11.3M	Buy	20,488 +8,783	+75%	+$5.03M	0.19%	59
2024 Q1	$6.8M	Buy	11,705 +10,464	+843%	+$5.87M	0.18%	56
2023 Q4	$659K	Sell	1,241 -113	-8%	-$54.7K	0.01%	163
2023 Q3	$685K	Buy	1,354 +560	+71%	+$298K	0.02%	160
2023 Q2	$414K	Buy	+794	New	+$428K	0.01%	173
2021 Q1	–	Sell	-3,784	Closed	-$1.76M	–	154
2020 Q4	$1.76M	Buy	+3,784	New	+$1.77M	0.1%	96

Other funds holding TMO

JSC

J. Stern & Co London, United Kingdom $1.06B AUM 11.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Partners Capital Investment Group's TMO Position: Q4 2025 in Review

Partners Capital Investment Group sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 8,056 shares — an estimated $3.91M sold.

Partners Capital Investment Group first reported a position in TMO in Q4 2020 and held it in 11 quarters. The position peaked at $12M in Q3 2024. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

Partners Capital Investment Group reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
Partners Capital Investment Group sold 8,056 Thermo Fisher Scientific shares in Q4 2025, an estimated $3.91M.
Partners Capital Investment Group first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 11 quarters.
Partners Capital Investment Group's Thermo Fisher Scientific position peaked at $12M in Q3 2024.
2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Partners Capital Investment Group's 13F filing for Q4 2025, filed 13 Feb 2026.